ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Short Communication
Antidiabetic Agents and the Recent Advances in Pharmacotherapy
DOI: 10.35248/0975-0851.15.13.545
Perspective
The Science of Bioequivalency Management and Generic Drugs
DOI: 10.35248/0975-0851.15.13.546
Deciphering Pharmacokinetics: Understanding the Dynamics of Drug Action
DOI: 10.35248/0975-0851.15.13.547
Exploring the Innovative Benefits of Clinical Trials in Drug Development
DOI: 10.35248/0975-0851.15.13.548
Commentary Article
Impact of Drug Release Dynamics on Drug Release Rate
DOI: 10.35248/0975-0851.15.13.549
Balance in Processing Complexity and Evaluating Formulation Differences
DOI: 10.35248/0975-0851.15.13.550
The Important Role of Pharmacological Drug Bioanalysis
DOI: 10.35248/0975-0851.15.13.551
Opinion
The Technique of Creating Dosage Forms for Improved Drug Delivery and Treatment Management
DOI: 10.35248/0975-0851.15.13.552
Using Noncompartmental Analysis to Maximize Pharmacokinetic Opportunities
DOI: 10.35248/0975-0851.15.13.553
Significance of Therapeutic Equivalency in Prescription Drugs
DOI: 10.35248/0975-0851.15.13.554